Avammune Therapeutics

Avammune Therapeutics is a company focused on immuno-oncology, particularly the development of drugs targeting the STING pathway. Avammune is developing a multimodal approach to modulate the STING pathway for cancer treatment. Their multimodal approach combines engineered viruses and small molecules.